Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
GSK2239633（一种 CC 趋化因子受体 4 拮抗剂）在健康男性受试者中的安全性、耐受性、药代动力学和药效学：一项开放标签研究和一项随机研究的结果
期刊:BMC Pharmacol Toxicol
影响因子:2.800
doi:10.1186/2050-6511-14-14.
Anthony Cahn, Simon Hodgson, Robert Wilson, Jonathan Robertson, Joanna Watson, Misba Beerahee, Steve C Hughes, Graeme Young, Rebecca Graves, David Hall, Sjoerd van Marle, Roberto Solari
